Introduction: We evaluate the technical feasibility of robotic prostatectomy in renal transplant recipients. Methods: We retrospectively analyzed preoperative and perioperative settings, as well as functional and oncologic results of 12 patients operated on between 2009 and 2013. Prostatectomy was performed via a transperitoneal approach without any changing in the ports position. The average age was 61.92 ± 2.98 years. The period between transplant and the diagnosis of adenocarcinoma was 79.7 months. The mean PSA was 7.34 ng/mL (range: 4.9-11). Results: The operative time was 241.3 ± 35.6 minutes with only one conversion and one transfusion. The intervention was difficult due to adhesions on the side of the graft in 50% of cases. There was a case of obstructive acute renal failure resulting from a hematoma of the Retzius treated by percutaneous nephrostomy at D20. There was a majority of pT2c (72.7%), including 3 positive margins (27.3%) and 2 biochemical relapses treated with radiotherapy and hormonotherapy, respectively. The end point prostate-specific antigen was undetectable. There was no significant difference between preoperative and J7 creatinine (p = 0. 22). Conclusions: Robotic prostatectomy in renal transplant recipients is a safe technique with no serious effects on the allograft. IntroductionFor patients with end-stage renal disease, renal transplantation is the best treatment in terms of patient survival and quality of life.1 However, the need for immunosuppressive therapy following transplantation increases the incidence of certain cancers, 2 including urological cancers. 3 Prostate cancer is the most common urological cancer in male renal transplant recipients, with an incidence of 3.1%. 3The functional and oncological results of radical prostatectomy in these patients remain poorly evaluated. The results of retropubic 4,5 and laparoscopic prostatectomy have been previously reported, 6-8 but few studies have evaluated robot-assisted laparoscopic prostatectomy. 9 We therefore evaluated the technical feasibility and oncological results of robot-assisted laparoscopic radical prostatectomy (RALP) in renal transplant recipients. MethodsThis single-centre retrospective study included 12 renal transplant recipients who underwent RALP between January 2009 and January 2013.Clinicom 2001 version 6.50.0102 (Cliniom, Inc.) was used for data collection and Fusion Pégase 4D version 4.0.0 (Fusion Pégase Inc.) was used for anesthetic data. RALP was performed according to the conventional technique with 6 transperitoneal trocars. Lymph node dissection was not performed on the side of the transplant.Clinical data (age at the time of prostatectomy, etiology of end-stage renal disease, interval between renal transplantation and prostatectomy, side of transplantation, immunosuppressive therapy, American Society of Anesthesiologists [ASA] score, body mass index [BMI], and Charlson comorbidity index) were recorded for each patient.The diagnosis of prostate cancer was established on the basis of digital rectal e...

Infection due to species other than Candida albicans is increasing among solid organ transplant recipients. Candida utilis, commonly used in the food industry, is considered as a low-virulence yeast. We report the first case of C. utilis fungaemia involving a solid organ transplant recipient. The infection was triggered by the withdrawal of a ureteral stent and was successfully treated with intravenous micafungin. We also propose a review of all reported cases of infection caused by C. utilis.

No abstract

No abstract

No abstract